Symons Capital Management’s Usana Health Sciences USNA Stock Holding History

Symons Capital Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,405	Closed	-$202K	–	77
2019 Q1	$202K	Buy	+2,405	New	+$251K	0.09%	55
2018 Q1	–	Sell	-5,181	Closed	-$384K	–	90
2017 Q4	$384K	Hold	5,181	–	–	0.11%	49
2017 Q3	$299K	Sell	5,181 -210	-4%	-$12.4K	0.08%	62
2017 Q2	$346K	Sell	5,391 -99	-2%	-$6.1K	0.08%	56
2017 Q1	$316K	Buy	5,490 +500	+10%	+$29.8K	0.08%	54
2016 Q4	$305K	Buy	+4,990	New	+$325K	0.07%	51

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Symons Capital Management's USNA Position: Q2 2019 in Review

Symons Capital Management sold out of Usana Health Sciences (USNA) in Q2 2019, closing a stake of 2,405 shares — an estimated $202K sold.

Symons Capital Management first reported a position in USNA in Q4 2016 and held it in 6 quarters. The position peaked at $384K in Q4 2017. 173 funds tracked by Wall St. Rank hold USNA as of Q2 2019.

Symons Capital Management reported no remaining Usana Health Sciences position as of Q2 2019 after selling out during the quarter.
Symons Capital Management sold 2,405 Usana Health Sciences shares in Q2 2019, an estimated $202K.
Symons Capital Management first reported a position in Usana Health Sciences in Q4 2016 and held it in 6 quarters.
Symons Capital Management's Usana Health Sciences position peaked at $384K in Q4 2017.
173 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2019.

Based on Symons Capital Management's 13F filing for Q2 2019, filed 12 Aug 2019.